Page 99 - Annual Report

HONG KONG ACADEMY OF MEDICINE
香 香港醫學專科學院
港
科
院
學
醫
專
學
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

15. DEFERRED INCOME
2024 2023
HK$ HK$

Current
Grant received from government 25,192,554 2,661,160
Grant received for research in genomic medicine 847,253 473,912
Others 2,640,224 88,830

28,680,031 3,223,902

Non-current
Grant received for research in genomic medicine 1,256,001 1,876,632

29,936,032 5,100,534

16. RESERVE AND FUNDS

Movements in components of reserve and funds

The reconciliation between the opening and closing balances of each component of the Group’s
consolidated reserve and funds is set out in the consolidated statement of changes in reserve and
funds. Details of the changes in the Academy’s individual components of reserve and funds between
the beginning and the end of the year are set out below:

The Academy

Fair value General
reserve fund Total
HK$ HK$ HK$

At 1 January 2023 (2,225,076) 76,112,577 73,887,501

Surplus for the year - 10,030,485 10,030,485
Other comprehensive loss
Investments in equity instruments designated at fair
value through other comprehensive income:
Changes in fair value (221,160) - (221,160)

Total comprehensive income/(loss) for the year (221,160) 10,030,485 9,809,325

At 31 December 2023 and 1 January 2024 (2,446,236) 86,143,062 83,696,826

Deficit for the year - (3,783,569) (3,783,569)
Other comprehensive income
Investments in equity instruments designated at fair
value through other comprehensive income:
Changes in fair value 1,629,564 - 1,629,564

Total comprehensive (loss)/income for the year 1,629,564 (3,783,569) (2,154,005)

At 31 December 2024 (816,672) 82,359,493 81,542,821

26

97
香港醫學專科學院 2025 年度報告